Klaria Pharma Holding AB (publ.) (STO:KLAR)
Sweden
· Delayed Price · Currency is SEK 0.9980
+0.0140 (1.42%)
May 7, 2025, 4:41 PM CET
STO:KLAR Revenue
In the year 2024, Klaria Pharma Holding AB (publ.) had annual revenue of 2.25M SEK. Klaria Pharma Holding AB (publ.) had revenue of 1.07M in the quarter ending December 31, 2024, a decrease of -114.92%.
Revenue
2.25M
Revenue Growth
n/a
P/S Ratio
63.36
Revenue / Employee
562.00K
Employees
4
Market Cap
142.44M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 997.85M |